Biotherapeutics, Inc.
Blacksburg, VA Doing business as Biotherapeutics Inc.
- UEI
- DKZNEQL174E3
- CAGE
- 6KFS9
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1800 Kraft Dr SW STE 200, Blacksburg, VA 24060, USA
- Website
- biotherapeuticsinc.com
- Founded
- 2008
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Biotherapeutics, Inc.
Biotherapeutics, Inc. is a clinical-stage biotechnology company headquartered in Blacksburg, Virginia, that specializes in developing novel precision medicine therapeutics for inflammatory, autoimmune, and infectious diseases. The company leverages advanced computational modeling and translational experimentation to accelerate the development of innovative first-in-class oral therapeutics targeting complex medical conditions. Registered in SAM.gov since October 2011, Biotherapeutics, Inc. is a for-profit corporate entity focused on discovering and advancing small molecule drug candidates with unique mechanisms of action that address significant unmet medical needs.
The company has received multiple federal grant awards primarily from agencies like the National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI), and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These Small Business Innovation Research (SBIR) grants have supported research and development efforts across various therapeutic areas, including treatments for Clostridioides difficile infection, inflammatory bowel disease, systemic lupus erythematosus, type 2 diabetes, asthma, psoriasis, and rheumatoid arthritis. The grant awards, ranging from approximately $288,000 to $719,000, focus on developing novel oral therapeutics that target specific immunoregulatory pathways, with aims to characterize therapeutic efficacy, pharmacokinetics, and potential translational impact in preclinical models and human cell studies. The research consistently emphasizes developing safer, more effective treatments with unique mechanisms of action that can address limitations in current standard-of-care therapies across these complex medical conditions.
Quick answers
What is Biotherapeutics, Inc.'s UEI?
Biotherapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is DKZNEQL174E3.
What is Biotherapeutics, Inc.'s CAGE code?
Biotherapeutics, Inc.'s CAGE code is 6KFS9.
Where is Biotherapeutics, Inc. located?
Biotherapeutics, Inc.'s physical address in SAM.gov is 1800 Kraft Dr SW STE 200, Blacksburg, VA 24060, USA.
Is Biotherapeutics, Inc. registered in SAM.gov?
Yes. Biotherapeutics, Inc.'s SAM.gov registration is active through June 24, 2027.
What is Biotherapeutics, Inc.'s most recent federal award?
Biotherapeutics, Inc.'s most recent federal grant award is Immunometabolic therapeutics for multiple sclerosis - immunometabolic therapeutics for multiple sclerosis… (R43AI197370), from National Institute of Allergy and Infectious Diseases, on September 1, 2026.
On GovTribe
See Biotherapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors